mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.4 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.4 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.038 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.11 |
0.4 |